Global Pharmaceutical Business Leader

Dr. Nisha Dolas Bhambure

22+ years of international experience across regulated and emerging pharmaceutical markets, with expertise in global growth, P&L leadership, business development, strategic partnerships and market expansion.

Portrait of Dr. Nisha Dolas Bhambure, global pharmaceutical business leader

22+

Years of pharmaceutical experience

₹250 Cr

International business leadership

$40M+

Institutional business experience

$48M

International portfolio experience

Executive Profile

Leadership at the Intersection of Strategy, Growth & Execution

Dr. Nisha Dolas Bhambure has spent more than two decades building, scaling and transforming international pharmaceutical businesses across regulated and emerging markets — from early export operations to leading international business, strategy and P&L.

Her work sits at the intersection of strategy and execution: setting direction for international markets, then owning the commercial detail that determines whether it succeeds — portfolio choices, pricing, partner selection, registrations and country operating models.

Capabilities

Areas of Expertise

01

International Business & Market Expansion

Building and scaling pharmaceutical businesses across regulated and emerging markets, from market entry assessment to registration-led launch planning and country-level commercial models.

02

Commercial Strategy & P&L Leadership

Owning international P&L, pricing and margin architecture, and translating strategy into operating plans that restore performance in underperforming markets and sustain profitable growth.

03

Business Development & Strategic Partnerships

Identifying, negotiating and structuring partnerships with distributors, marketing partners and manufacturers, and managing those relationships through long commercial cycles.

04

Licensing, M&A & Joint Ventures

Evaluating in-licensing and out-licensing opportunities, joint ventures and cross-border acquisition targets, including commercial diligence and post-deal business planning.

05

Institutional & Global Health Business

Experience with institutional, tender-driven and global-health business, where access, supply reliability and long procurement cycles determine commercial outcomes.

06

Portfolio & Product Strategy

Shaping country-appropriate portfolios: selecting molecules and dosage forms, sequencing filings and balancing near-term revenue with sustainable long-term products.

07

Leadership & Capability Building

Building and mentoring international commercial teams, and developing the market, negotiation and portfolio capability that international pharmaceutical businesses depend on.

Geographic Scope

International Pharmaceutical Experience

EuropeANZCISMENAAfricaSoutheast AsiaLATAM

Experience spans regulated and emerging markets with materially different registration pathways, channel structures and pricing dynamics — private market, distributor-led and institutional business alike.

Career Journey

Two Decades in International Pharma

  1. 2018 — Present

    Brooks Laboratories Ltd

    International Business — Emerging Markets, Strategy, P&L & Business Development

    • Leads international business across emerging and regulated markets with ownership of strategy, P&L and growth.
    • Drives business development, licensing and CDMO opportunities alongside new market expansion.
    • Develops strategic partnerships and country entry plans supported by portfolio and pricing strategy.
  2. 2005 — 2018

    Cipla

    International Business & Strategy / Global Access

    • Progressed through international business and strategy roles across multiple geographies.
    • Worked across global access and institutional business, including tender-driven and global-health demand.
    • Contributed to market expansion, portfolio strategy and partner management across diverse regions.
  3. 2004 — 2005

    Glenmark Pharmaceuticals

    Export / International Business

    • Supported export and international business operations across overseas markets.
  4. 2003 — 2004

    Transchem Corporation Pharma Pvt Ltd

    Exports Officer

    • Began her career in pharmaceutical exports, handling documentation and overseas order execution.

Evidence

Selected Leadership Impact

International Business & P&L Leadership

Opportunity
International operations spread across markets with uneven performance.
Contribution
Took ownership of strategy and P&L, reset priorities by market and rebuilt the operating plan.
Impact
Leadership of international business of the order of ₹250 Cr with a clearer growth base.

Global Market Expansion

Opportunity
Growth concentrated in a limited set of geographies.
Contribution
Assessed and entered new markets across Europe, ANZ, CIS, MENA, Africa, Southeast Asia and LATAM.
Impact
A broader, more balanced international footprint across regulated and emerging markets.

Strategic Partnerships & Joint Ventures

Opportunity
Market access in several territories required local capability and presence.
Contribution
Structured partner and joint-venture arrangements aligned to portfolio and regulatory realities.
Impact
Partnerships that opened routes to market without disproportionate fixed investment.

Licensing & Business Development

Opportunity
Need to add commercially viable products beyond the existing pipeline.
Contribution
Evaluated in-licensing, out-licensing and CDMO opportunities on commercial and regulatory fit.
Impact
A business development pipeline linked directly to country-level portfolio needs.

Institutional & Global Health Business

Opportunity
Institutional demand governed by long procurement cycles and strict qualification.
Contribution
Aligned portfolio, supply commitments and pricing to institutional and global-health requirements.
Impact
Institutional business experience of the order of $40M+.

Cross-Border M&A Perspectives

Opportunity
Inorganic options considered as a route to capability and market access.
Contribution
Contributed to the commercial evaluation of cross-border targets and post-deal business logic.
Impact
Structured assessments of acquisition opportunities against strategic priorities.

Engagement

Consulting & Strategic Advisory

Drawing on more than two decades of international pharmaceutical leadership, Dr. Nisha works with organisations and professionals seeking practical perspectives on growth, market expansion, commercial strategy and leadership.Discuss a Requirement

  • International Market Expansion
  • Commercial & Growth Strategy
  • Business Development & Partnerships
  • Licensing / JV / M&A Perspectives
  • Portfolio & Product Strategy
  • Pharma Leadership Advisory

Learning

Training & Executive Development

Selected training and workshop themes can be tailored for pharmaceutical organisations, leadership teams and professionals.

  • International Pharma Business
  • Global Market Expansion
  • Business Development
  • Strategic Partnerships
  • Commercial Strategy
  • Portfolio Management
  • Leadership in Pharmaceutical Organisations
  • Building Sustainable International Businesses
  • Women in Leadership
  • Career Development for Pharma Professionals
Enquire About Training

Academic Depth

From Industry Experience to Academic Inquiry

Doctor of Philosophy (PhD) in Management

Apex University, Jaipur · 2022 — 2026

Research area: Pradhan Mantri Bharatiya Jan Aushadhi Pariyojana

The doctorate extends a long industry career rather than sitting apart from it. Two decades of commercial decisions in international markets, combined with management education and structured research, bring a different kind of rigour to questions of access, affordability and sustainable pharmaceutical business models.

Research & Publications — coming soon.

Education

  • PhD in Management

    Apex University, Jaipur

    2022 — 2026

  • Masters in Marketing Management

    Chetana's R.K. Institute of Management and Research

    2006 — 2009

  • M.Com

    University of Mumbai

    2000 — 2002

  • B.Com

    University of Mumbai

    1996 — 1999

Thought Leadership

Perspectives on Pharma, Leadership & Global Growth

Forthcoming

Global market expansion

Written perspectives will be published here. In the meantime, current commentary appears on LinkedIn.

Forthcoming

Leadership in pharma organisations

Written perspectives will be published here. In the meantime, current commentary appears on LinkedIn.

Forthcoming

Healthcare access & policy

Written perspectives will be published here. In the meantime, current commentary appears on LinkedIn.

Read My LinkedIn

Contact

Let's Start a Conversation

For consulting, advisory, training, speaking or professional enquiries, please share a few details and Dr. Nisha will respond directly.

nishabhambure02@gmail.com View LinkedIn Profile